Kinect 4: A phase 3, one-year, open-label trial of valbenazine in participants with tardive dyskinesia

Authors
Category Primary study
ConferenceNeuropsychopharmacology
Year 2017
This article has no abstract
Epistemonikos ID: a1ff4183124e331db80d85f4ea5a5f0a4b623989
First added on: Apr 29, 2026